Risk Factors for Failure After 1-Stage Exchange Total Knee Arthroplasty in the Management of Periprosthetic Joint Infection
Adult
Aged, 80 and over
Male
Arthritis, Infectious
Prosthesis-Related Infections
Middle Aged
Prosthesis Failure
3. Good health
03 medical and health sciences
Logistic Models
0302 clinical medicine
Risk Factors
Odds Ratio
Humans
Female
Arthroplasty, Replacement, Knee
Knee Prosthesis
Aged
Retrospective Studies
DOI:
10.2106/jbjs.18.00947
Publication Date:
2019-06-20T08:53:58Z
AUTHORS (7)
ABSTRACT
Background: One-stage exchange arthroplasty in the management of periprosthetic joint infection was introduced at our institution. The purpose this study to analyze risk factors failure after following total knee treated with 1-stage exchange. Methods: Ninety-one patients who underwent failed treatment due from January 2008 December 2017 were included. From same period, we randomly selected a 1:1 matched control group without subsequent revision surgical procedure. Bivariate analyses, including preoperative, intraoperative, and postoperative factors, as well logistic regression, performed identify for failure. Results: analysis yielded 10 predictors (variables significance p < 0.05) involving re-revision any reason 11 reinfection. binary regression model revealed reason: history (odds ratio [OR], 26.706 [95% confidence interval (CI), 5.770 123.606]; 0.001), 2-stage (OR, 3.948 CI, 1.869 8.339]; isolation enterococci 16.925 2.033 140.872]; = 0.009). reinfection or arthroplasty, enterococci, streptococci 6.025 1.470 24.701]; 0.013). Conclusions: We identified several infection, most which not related patient comorbidities. Among them, previous Enterococcus Streptococcus species associated higher Besides multidisciplinary approach, being aware when evaluating could lead better outcomes. Level Evidence: Prognostic III . See Instructions Authors complete description levels evidence.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (43)
CITATIONS (56)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....